Crosslink Capital Disposed 1.5 Million Shares of Pandora Media Inc (P)

Crosslink Capital, managed by Seymour Sy Kaufman and Michael Stark, dumped 1.5 million shares of Pandora Media Inc (NYSE:P). According to the filing with the Securities and Exchange Commission, 1.0 million shares of the company have been distributed to investors for no considerations, while 500,000 shares have been sold at $35.87 per share. After the transactions, Crosslink Capital owns 18.77 million shares of the company.

pandora

There are other hedge fund managers who have been bullish about Pandora Media Inc (NYSE:P). Crosslink Capital, even after reducing its stake in the company, still remains the largest shareholder. Among other hedge funds from our database, Philippe Laffont’s Coatue Management reported an ownership of 5.71 million shares of the company in its latest 13F, boosting the position by 4.58 million shares over the quarter. Donald Chiboucis’s Columbus Circle Investors has also been bullish during the last quarter of 2013 and upped its stake by 1.72 million shares to some 5.67 million shares.

Crosslink Capital is a fund that is as vertically integrated as investing gets. It invests heavily in services and technology sectors, picking companies at all stages from seed financing to the public markets.

Pandora Media Inc (NYSE:P) is an internet radio operator in the United States. The company had over 125 million registered users as of January, 2012. The company’s the Music Genome Project characterized by an algorithm which predicts listeners’ music preferences and offers new music that fits the subscribers’ taste. The company generates revenue from advertising. The company provides service through Free Service and Pandora One.

Disclosure: none

Recommended Reading:

Ackman’s Pershing Square Cuts Its Stake in Beam Inc (BEAM)

John Burbank’s Largest Stock Picks

Jonathan Auerbach’s Hound Partners’ Top Stock Picks

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!